Neurobo Pharmaceuticals Correlations

Summary

NRBODelisted Stock

USD 1.89 0.25 11.68%

The current 90-days correlation between Neurobo Pharmaceuticals and Cardio Diagnostics Holdings is -0.23 (i.e., Very good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Neurobo Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Neurobo Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Neurobo Pharmaceuticals Correlation With Market

Significant diversification

The correlation between Neurobo Pharmaceuticals and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Neurobo Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Moving together with Neurobo Stock

0.79	HNHPF	Hon Hai Precision	Pair Corr
0.74	HPQ	HP Inc	Pair Corr
0.63	XOM	Exxon Mobil Corp Fiscal Year End 7th of February 2025	Pair Corr
0.61	TRV	The Travelers Companies	Pair Corr

Moving against Neurobo Stock

0.69	AXP	American Express	Pair Corr
0.67	AMZN	Amazon Inc Earnings Call This Week	Pair Corr
0.62	JPM	JPMorgan Chase	Pair Corr
0.58	WMT	Walmart Aggressive Push	Pair Corr
0.55	VWAPY	Volkswagen AG Pref	Pair Corr
0.55	V	Visa Class A	Pair Corr
0.49	VLKAF	Volkswagen AG	Pair Corr
0.49	VLKPF	Volkswagen AG VZO	Pair Corr
0.47	VWAGY	Volkswagen AG 110	Pair Corr
0.4	CHKP	Check Point Software Earnings Call This Week	Pair Corr
0.38	IBM	International Business Tech Boost	Pair Corr
0.35	MSFT	Microsoft	Pair Corr

Related Correlations Analysis

	ALLR	HILS	VRAX	QNRX	KRBP	BDRX	ZURA	PHIO	SONN	ATNF
ALLR		0.62	0.11	0.07	0.53	0.54	0.67	0.15	0.75	0.66	ALLR
HILS	0.62		0.23	0.46	0.37	0.67	0.68	0.26	0.83	0.8	HILS
VRAX	0.11	0.23		0.07	0.02	0.13	0.1	-0.02	0.17	0.03	VRAX
QNRX	0.07	0.46	0.07		0.33	0.61	0.62	0.26	0.54	0.61	QNRX
KRBP	0.53	0.37	0.02	0.33		0.5	0.77	0.14	0.68	0.65	KRBP
BDRX	0.54	0.67	0.13	0.61	0.5		0.72	0.37	0.77	0.78	BDRX
ZURA	0.67	0.68	0.1	0.62	0.77	0.72		0.25	0.88	0.92	ZURA
PHIO	0.15	0.26	-0.02	0.26	0.14	0.37	0.25		0.3	0.26	PHIO
SONN	0.75	0.83	0.17	0.54	0.68	0.77	0.88	0.3		0.9	SONN
ATNF	0.66	0.8	0.03	0.61	0.65	0.78	0.92	0.26	0.9		ATNF
	ALLR	HILS	VRAX	QNRX	KRBP	BDRX	ZURA	PHIO	SONN	ATNF

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ATNF	+ 0.92	ZURA
ATNF	+ 0.9	SONN
SONN	+ 0.88	ZURA
SONN	+ 0.83	HILS
ATNF	+ 0.8	HILS
ATNF	+ 0.78	BDRX

High negative correlations

PHIO

- 0.02

VRAX

Risk-Adjusted Indicators

There is a big difference between Neurobo Stock performing well and Neurobo Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Neurobo Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ALLR	4.38	(0.16)	0.00	(0.50)	0.00	0.00	6.93	(8.33)	37.19
HILS	5.56	(0.28)	0.00	0.17	0.00	0.00	8.33	(7.89)	113.15
VRAX	6.32	(0.04)	0.00	0.11	0.00	0.00	19.90	(11.28)	59.66
QNRX	5.42	(1.26)	0.00	739.22	0.00	0.00	14.29	(9.59)	58.63
KRBP	6.00	(0.17)	0.00	(6.01)	0.00	0.00	12.04	(10.96)	65.24
BDRX	4.35	(0.56)	0.00	(0.45)	0.00	0.00	10.02	(6.91)	33.99
ZURA	4.40	(1.27)	0.00	9.27	0.00	0.00	9.21	(11.55)	25.04
PHIO	11.72	2.17	0.21	0.67	10.35	(17.83)	12.33	(11.53)	336.29
SONN	4.97	(1.66)	0.00	19.78	0.00	0.00	9.38	(14.50)	44.37
ATNF	5.11	(1.20)	0.00	(1.77)	0.00	0.00	9.79	(9.97)	79.11

Delisting Warning - NRBO

Neurobo Pharmaceuticals was delisted

The entity Neurobo Pharmaceuticals with a symbol NRBO was delisted from NASDAQ Exchange. Please try MetaVia with a symbol MTVA from now on. Check all delisted instruments accross multiple markets.

Neurobo Pharmaceuticals Corporate Management

PharmD BCPS	VP Operations	Profile
Robert Homolka	Senior Operations	Profile
Ben MD	CEO Pres	Profile
Frank Kondrad	VP Devel	Profile
MiKyung Kim	Chief Officer	Profile

Still Interested in Neurobo Pharmaceuticals?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC